Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Vascular Patches Market, by Material
1.4.2 Europe Vascular Patches Market, by End User
1.4.3 Europe Vascular Patches Market, by Application
1.4.4 Europe Vascular Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Vascular Patches Market
Chapter 4. Europe Vascular Patches Market by Material
4.1 Europe Biologic Market by Country
4.2 Europe Synthetic Market by Country
Chapter 5. Europe Vascular Patches Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Ambulatory Surgical Centers Market by Country
Chapter 6. Europe Vascular Patches Market by Application
6.1 Europe Carotid Endarterectomy Market by Country
6.2 Europe Open Repair of Abdominal Aortic Aneurysm Market by Country
6.3 Europe Vascular Bypass Surgery Market by Country
6.4 Europe Congenital Heart Disease Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Vascular Patches Market by Country
7.1 Germany Vascular Patches Market
7.1.1 Germany Vascular Patches Market by Material
7.1.2 Germany Vascular Patches Market by End User
7.1.3 Germany Vascular Patches Market by Application
7.2 UK Vascular Patches Market
7.2.1 UK Vascular Patches Market by Material
7.2.2 UK Vascular Patches Market by End User
7.2.3 UK Vascular Patches Market by Application
7.3 France Vascular Patches Market
7.3.1 France Vascular Patches Market by Material
7.3.2 France Vascular Patches Market by End User
7.3.3 France Vascular Patches Market by Application
7.4 Russia Vascular Patches Market
7.4.1 Russia Vascular Patches Market by Material
7.4.2 Russia Vascular Patches Market by End User
7.4.3 Russia Vascular Patches Market by Application
7.5 Spain Vascular Patches Market
7.5.1 Spain Vascular Patches Market by Material
7.5.2 Spain Vascular Patches Market by End User
7.5.3 Spain Vascular Patches Market by Application
7.6 Italy Vascular Patches Market
7.6.1 Italy Vascular Patches Market by Material
7.6.2 Italy Vascular Patches Market by End User
7.6.3 Italy Vascular Patches Market by Application
7.7 Rest of Europe Vascular Patches Market
7.7.1 Rest of Europe Vascular Patches Market by Material
7.7.2 Rest of Europe Vascular Patches Market by End User
7.7.3 Rest of Europe Vascular Patches Market by Application
Chapter 8. Company Profiles
8.1 Edwards Lifesciences Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Baxter International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Lemaitre Vascular, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Aziyo Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Artivion, Inc. (CryoLife, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. W. L. Gore & Associates, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Unique Offerings 
